Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir ...

During a live event, Ahmad Tarhini, MD, PhD, and participants discussed how to use combination immunotherapy in patients with ...

May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

A Philadelphia cancer patient will be honored at the Phillies' game on Tuesday night. Josh Breen, who was diagnosed with ...

Melanoma is the most prevalent cancer during pregnancy, representing 31% of all gestational cancers, and that number is ...

Josh Breen, who was diagnosed with stage 3 melanoma last year, will throw out the first pitch at Tuesday's Phillies' game as ...

Existing drug class may help patients with skin cancer to resist standard treatments: Study: New York Friday, June 13, 2025, 16:00 Hrs [IST] An increased activity in a specific bi ...

Emerging research is uncovering how a fiber-rich, whole-foods-based diet may help support better outcomes for patients ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

An innovative treatment called lifileucel, which uses a patient's own immune system to combat advanced melanoma, has shown ...

Mitochondrial DNA emerges as a key factor in melanoma checkpoint inhibitor resistance, revealing new potential biomarker for patients.